{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/fibroids/management/management/","result":{"pageContext":{"chapter":{"id":"0dcebc15-0b4a-5898-9e9d-bdce5879ed3d","slug":"management","fullItemName":"Scenario: Management","depth":2,"htmlHeader":"<!-- begin field 50b9eb6f-1625-4925-909a-0523c6773a4e --><h2>Scenario: Management of fibroids</h2><!-- end field 50b9eb6f-1625-4925-909a-0523c6773a4e -->","summary":"Covers the management of women with fibroids.","htmlStringContent":"<!-- begin item bad10a2f-ff24-4a3b-8e24-2f830f0ca75d --><!-- begin field 1271354a-862b-4ef0-b3c4-acbd008943ff --><p>From age 16 years onwards (Female).</p><!-- end field 1271354a-862b-4ef0-b3c4-acbd008943ff --><!-- end item bad10a2f-ff24-4a3b-8e24-2f830f0ca75d -->","topic":{"id":"6463a640-e4df-5049-8bb4-6654ab8b15ce","topicId":"3fd67974-f2c5-44ed-822f-084a7bfa2b77","topicName":"Fibroids","slug":"fibroids","lastRevised":"Last revised in December 2018","chapters":[{"id":"17b509af-8275-5623-a47b-ec3301ad1e00","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"dd45c961-3e46-592b-93bd-04eac254ce78","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"cc8303eb-62bc-5f8f-b697-83157c2c4fe7","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"f79d0226-1517-5e54-aab7-8835d760b8cc","slug":"changes","fullItemName":"Changes"},{"id":"767a9892-20df-5979-bed9-cffded6848c6","slug":"update","fullItemName":"Update"}]},{"id":"7b24582e-8917-5b59-a8bf-73b8769a2e86","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"96c90f71-050c-59fa-aedc-953048783302","slug":"goals","fullItemName":"Goals"},{"id":"e4a2aeb9-62f9-58bb-a248-c1dc9358b254","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"1666f790-8ff1-5ba8-95de-23a735364bc8","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"f35cbfa6-b4fc-574b-8eb6-7df9e8070976","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"c597adf8-a842-51ae-88e6-441cacfbdfc9","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"f1a497a7-9324-5e43-bc01-3b33e344ff83","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"18d5fa10-3213-5357-9062-7b0e16a0a785","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"38f26131-0aa0-5700-a6fd-25bd7a26503a","slug":"definition","fullItemName":"Definition"},{"id":"ee0338f8-7167-58f0-8c50-1aab97a3b27e","slug":"prevalence","fullItemName":"Prevalence"},{"id":"709492e8-0053-5ca6-8a20-ddfabff85694","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"b7f5350a-2c61-535b-bb44-cd9c51132b57","slug":"natural-history-of-fibroids","fullItemName":"Natural history of fibroids"},{"id":"e3765a3b-c1e7-5221-acb7-cc000b1de1c5","slug":"complications","fullItemName":"Complications"}]},{"id":"3c5ed9b8-5b6d-5b68-8d15-b9e7b15a8d1d","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"b98686e1-b4a2-5937-9e77-a1aa76faec11","slug":"assessment","fullItemName":"Assessment"},{"id":"137f352c-c6be-56ed-bfaf-8627d692a159","slug":"signs-symptoms","fullItemName":"Signs and symptoms"},{"id":"0a19e969-b9fc-5a47-99d1-f81fa33bfcc2","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"26643766-7cf9-532d-8dc9-a1ca4a679b5c","fullItemName":"Management","slug":"management","subChapters":[{"id":"0dcebc15-0b4a-5898-9e9d-bdce5879ed3d","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"16c07bd4-71e3-573e-a85f-190156235c98","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"4bbe6ec3-6612-56ee-bd5d-3bac8fc870aa","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"eec2e9fc-14b3-52df-b3f8-853d2bd020c1","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"f9855d83-db65-5e68-b06a-bfd8533e2b6b","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"8a30e797-0317-501c-96a6-0c96f08d306e","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"94bd4428-5492-5e06-854c-3f6747917258","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"41c7124d-fd7d-5771-9ef3-cff4588a2f3b","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"a166d27d-9883-5200-a62f-532b916906ea","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"26643766-7cf9-532d-8dc9-a1ca4a679b5c","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"a83d240c-f657-5cc4-880d-11620e71d886","slug":"management","fullItemName":"Management","depth":3,"htmlHeader":"<!-- begin field 98df41e5-0326-4f53-9eac-dc2ab1ca498a --><h3>How should I manage fibroids?</h3><!-- end field 98df41e5-0326-4f53-9eac-dc2ab1ca498a -->","summary":null,"htmlStringContent":"<!-- begin item b85f0569-5420-4357-aab1-cc12d50664a4 --><!-- begin field ed1a6682-8a12-4b20-b24f-5d5f2d783385 --><ul><li><strong>If imaging shows the presence of uterine fibroids, appropriate treatment should be planned with the woman, based on the size, number, and location of the fibroids and her symptoms. </strong><ul><li><strong>Refer to a specialist, women with: </strong><ul><li>Complications, such as compressive symptoms from large fibroids (for example dyspareunia, pelvic pain or discomfort, constipation, or urinary symptoms).</li><li>Fertility or obstetric problems associated with fibroids — for more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/infertility/\">Infertility</a>.</li><li>A clinical or radiological suspicion of malignancy.</li><li>Fibroids which are palpable abdominally, or intracavity fibroids and/or whose uterine length is measured at ultrasound, or hysteroscopy, greater than 12 cm.</li></ul></li><li><strong>For women with fibroids that are asymptomatic</strong><strong>:</strong><ul><li>The majority of women require no further investigation or treatment once diagnosed unless there is rapid growth or reason to suspect pelvic malignancy.</li><li>Arrange annual follow up to monitor size and growth.</li></ul></li><li><strong>For women with menorrhagia associated with fibroids, </strong>see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/menorrhagia/\">Menorrhagia</a> for management information.</li></ul></li></ul><!-- end field ed1a6682-8a12-4b20-b24f-5d5f2d783385 --><!-- end item b85f0569-5420-4357-aab1-cc12d50664a4 -->","subChapters":[{"id":"4e35e849-ce5f-5420-8af6-8b323ce5ced8","slug":"basis-for-recommendation-d58","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field a71f1ee0-6483-48cc-84e2-d989970895fd --><h4>Basis for recommendation</h4><!-- end field a71f1ee0-6483-48cc-84e2-d989970895fd -->","summary":null,"htmlStringContent":"<!-- begin item d58479de-cda6-4bb7-ad32-4089aedfa1c2 --><!-- begin field 2e0d4cac-e3e9-4c0c-81bf-c3655331ea1e --><p>These recommendations are based on the British Medical Journal (BMJ) best practice guide <em>Uterine fibroids</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fibroids/references/\">BMJ, 2017</a>], the National Institute for Health and Clinical Excellence (NICE) guideline <em>Heavy menstrual bleeding: assessment and management </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/fibroids/references/\">NICE, 2018</a>]<em>, </em>and expert opinion in a narrative review <em>Fibroids: diagnosis and management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fibroids/references/\">Lumsden, 2015</a>].</p><h5>Specialist referral</h5><ul><li>Expert opinion in a narrative review recommends that women with symptomatic fibroids which do not respond to initial treatments require referral to secondary care [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fibroids/references/\">Lumsden, 2015</a>].</li><li>CKS consider that in these circumstances, referral to a specialist is warranted to consider other medical and/or surgical treatment options.</li></ul><!-- end field 2e0d4cac-e3e9-4c0c-81bf-c3655331ea1e --><!-- end item d58479de-cda6-4bb7-ad32-4089aedfa1c2 -->","subChapters":[]}]},{"id":"39d406bd-cb42-5ae1-bd8f-2e984cd846a7","slug":"contraception","fullItemName":"Contraception","depth":3,"htmlHeader":"<!-- begin field c15bff4a-7581-4b02-9b57-1d3c7da3e615 --><h3>What methods of contraception are recommended for women with fibroids?</h3><!-- end field c15bff4a-7581-4b02-9b57-1d3c7da3e615 -->","summary":null,"htmlStringContent":"<!-- begin item 2e17271d-92c9-41c3-9f6b-6539c7b89d2e --><!-- begin field 868ba0b9-cc84-4686-9400-e91d9a96cb78 --><ul><li><strong>For women with uterine fibroids:</strong><ul><li><strong>Without </strong>distortion of the uterine cavity — all methods can be used.<ul><li>However, depending on the location and size of the fibroid, sterilization may be difficult.</li></ul></li><li><strong>With </strong>distortion of the uterine cavity — advise the woman to use one of the following methods:<ul><li>Barrier methods (condoms, diaphragms, and caps).</li><li>Combined hormonal contraception (pill, transdermal patch, or combined vaginal ring).</li><li>Progestogen-only pill (POP), progestogen-only implant, or progestogen-only injectable.</li><li>Female sterilization — depending on the location and size of the fibroid, sterilization may be difficult.</li></ul></li><li>Consider the following methods only after seeking specialist advice as the risks usually outweigh the benefits:<ul><li>Copper intrauterine device (Cu-IUD) or levonorgestrel intrauterine system (LNG-IUS) — these may be difficult to fit. </li></ul></li></ul></li><li>For more information, see the section on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-assessment/management/comorbidities-special-situations/#menorrhagia-fibroids-or-previous-ectopic-pregnancy\">fibroids</a> in CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-assessment/\">Contraception - assessment</a>.</li></ul><!-- end field 868ba0b9-cc84-4686-9400-e91d9a96cb78 --><!-- end item 2e17271d-92c9-41c3-9f6b-6539c7b89d2e -->","subChapters":[{"id":"b30748b7-a30a-57d7-b062-6aa7f5d8fe9e","slug":"basis-for-recommendation-2c1","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 41aa15f2-fec8-4e45-b915-44aa31b13290 --><h4>Basis for recommendation</h4><!-- end field 41aa15f2-fec8-4e45-b915-44aa31b13290 -->","summary":null,"htmlStringContent":"<!-- begin item 2c18b21c-1ace-478b-9d8c-9d64609c0a79 --><!-- begin field 21fb7ba6-0c92-4046-bbbb-d6ee53e62cd1 --><p>These recommendations are based on the Faculty of Sexual and Reproductive Healthcare (FSRH) <em>UK medical eligibility criteria for contraceptive </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/fibroids/references/\">FSRH, 2016</a>]<em> </em>and<em> </em>the World Health Organization (WHO) guidance <em>Medical eligibility for contraceptive use </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/fibroids/references/\">WHO, 2015</a>].</p><!-- end field 21fb7ba6-0c92-4046-bbbb-d6ee53e62cd1 --><!-- end item 2c18b21c-1ace-478b-9d8c-9d64609c0a79 -->","subChapters":[]}]},{"id":"523ea4a4-0948-5052-8a1c-6fdded69e8c9","slug":"hormone-replacement-therapy","fullItemName":"Hormone replacement therapy","depth":3,"htmlHeader":"<!-- begin field 4a18d964-4a25-4567-b2a4-a82ee5241433 --><h3>Can I prescribe HRT for women with fibroids?</h3><!-- end field 4a18d964-4a25-4567-b2a4-a82ee5241433 -->","summary":null,"htmlStringContent":"<!-- begin item 6fbb1a1a-df18-49fd-ac3b-30986fc74d36 --><!-- begin field c77f7898-bd15-4e87-a6c0-762c0b1bc85a --><ul><li><strong>For women with no symptoms from their fibroids:</strong><ul><li>The decision to treat menopausal symptoms with hormone replacement therapy (HRT) should be taken by the woman after she has been informed of the possible risks and benefits of treatment (as for all women considering HRT). This should include an explanation that:<ul><li>In some women, HRT may modestly increase fibroid size. If this occurs, there is a small risk that it will cause symptoms.</li></ul></li><li>After starting HRT in women with fibroids:<ul><li>Enquire about symptoms from fibroids at each review, and advise the woman to return for an early review if symptoms develop at any time. For more information, see the section on <a class=\"topic-reference external-reference\" href=\"/topics/menopause/management/management-of-menopause-perimenopause-or-premature-ovarian-insufficiency/#hormone-replacement-therapy-hrt\">Managing menopausal symptoms with HRT</a> in the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/menopause/\">Menopause</a>.</li></ul></li></ul></li><li><strong>For women with symptoms attributable to fibroids, </strong>seek specialist advice before prescribing HRT.</li></ul><!-- end field c77f7898-bd15-4e87-a6c0-762c0b1bc85a --><!-- end item 6fbb1a1a-df18-49fd-ac3b-30986fc74d36 -->","subChapters":[{"id":"b6a51c97-ac6f-522d-8f8b-53eef3efeaa1","slug":"basis-for-recommendation-cb5","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 6388495e-8817-4d7b-99c6-e3e764aff521 --><h4>Basis for recommendation</h4><!-- end field 6388495e-8817-4d7b-99c6-e3e764aff521 -->","summary":null,"htmlStringContent":"<!-- begin item cb5f2f3f-c89d-4eeb-b24c-2632ec6e8098 --><!-- begin field b8bb7767-7619-4600-87e3-d8f103616624 --><p>These recommendations are based on expert opinion in narrative reviews <em>Fibroids: diagnosis and management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fibroids/references/\">Lumsden, 2015</a>], and <em>Etiology, symptomatology, and diagnosis of uterine myomas</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fibroids/references/\">Parker, 2007</a>], and what CKS considers good clinical practice. </p><ul><li>Hormonal replacement therapy (HRT) may cause some growth of fibroids, but this is of uncertain clinical importance [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fibroids/references/\">Lumsden, 2015</a>].</li><li>The risk of symptoms due to fibroid enlargement caused by HRT is considered by experts to be low [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fibroids/references/\">Parker, 2007</a>].</li></ul><!-- end field b8bb7767-7619-4600-87e3-d8f103616624 --><!-- end item cb5f2f3f-c89d-4eeb-b24c-2632ec6e8098 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}